Physician

Robert Allan Prinzi, MD

According to 2025 Medicare claims, Robert Prinzi, MD (NPI: 1508131954) practices ophthalmology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is SOUTH CAROLINA RETINA INSTITUTE LLC (NPI: 1417581638; TIN: 843234305) and primary practice location at 29572-9998.

Prinzi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 942 traditional Medicare patients, billed 68,686 HCPCS/CPT codes, and received $3,232,976 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 263 prescription claims across 119 beneficiaries totaling $19,167 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 11 records totaling $275. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,761 to $3,232,976. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $20,785 to $19,167. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.9M$5.7M2016 Medicare payment: $4,761 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $358,103 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,077,305 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,159,807 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,782,254 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,573,541 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,369,460 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,720,614 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,232,976 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20163662$4,761
20179272,934$358,103
20181,8888,983$1,077,305
20192,16514,366$2,159,807
20201,94415,405$2,782,254
20212,00625,880$5,573,541
20221,76438,561$5,369,460
20231,43988,897$5,720,614
202494268,686$3,232,976

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$47K$93K2015 Drug cost: $20,785 (USD; Tot_Drug_Cst)2016 Drug cost: $23,964 (USD; Tot_Drug_Cst)2017 Drug cost: $17,905 (USD; Tot_Drug_Cst)2018 Drug cost: $55,249 (USD; Tot_Drug_Cst)2019 Drug cost: $68,720 (USD; Tot_Drug_Cst)2020 Drug cost: $93,238 (USD; Tot_Drug_Cst)2021 Drug cost: $66,646 (USD; Tot_Drug_Cst)2022 Drug cost: $68,627 (USD; Tot_Drug_Cst)2023 Drug cost: $49,644 (USD; Tot_Drug_Cst)2024 Drug cost: $19,167 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015120422$20,785
2016126629$23,964
2017145265$17,905
2018241593$55,249
2019243777$68,720
2020206594$93,238
2021214548$66,646
2022253731$68,627
2023189512$49,644
2024119263$19,167

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5561,851$81
92014Established patient complete exam of visual system249279$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more370460$64
J2777Injection, faricimab-svoa, 0.1 mg26159,700$27
92134Imaging of retina8042,108$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate743,043$2,694
Ketorolac TromethamineKetorolac Tromethamine26844$825
LatanoprostLatanoprost371,946$435
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat12938$195

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$275Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert Allan Prinzi, MD?

Tedicare shows public-source Medicare data for Robert Allan Prinzi, MD (NPI 1508131954), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Allan Prinzi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Allan Prinzi, MD?

Robert Allan Prinzi, MD is linked to SOUTH CAROLINA RETINA INSTITUTE LLC (billing NPI 1417581638) in the available physician profile data.

Does Robert Allan Prinzi, MD have Open Payments data?

Robert Allan Prinzi, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.